Reaction

Cutis Laxa reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 268 reports · 2 co-occurring drugs

As of the last recalculation, Cutis Laxa appears in 268 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 91.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ranibizumab2891.491.5
Onabotulinumtoxina2122.822.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.